Omalizumab treatment for chronic spontaneous urticaria coinciding with marked improvement of vitiligo: a case report. [PDF]
Lin S, Zhou P, Huang S, Li K, Zhang L.
europepmc +1 more source
Pediatric spontaneous-reporting patterns for biologics approved or used for asthma: Analysis of the FDA adverse event reporting system. [PDF]
Zhang Y, Liu Y, Chen L, Chen Y, Zheng X.
europepmc +1 more source
Omalizumab-based therapy in normocomplementemic urticarial vasculitis: a retrospective case series of 18 patients. [PDF]
Kayiran MA +3 more
europepmc +1 more source
Biologics for Children and Adolescents with Asthma: A Systematic Review and Exploratory Indirect Comparative Analysis. [PDF]
Wu M +8 more
europepmc +1 more source
Control first, tolerance second: biologics as enablers of allergen immunotherapy in severe allergic asthma. [PDF]
Jentzsch B +8 more
europepmc +1 more source
Integrated Traditional Chinese and Western Medicine for Chronic Spontaneous Urticaria: Protocol for a Trials Within Cohorts Study. [PDF]
Li L +8 more
europepmc +1 more source
Prognosis and Efficacy of Omalizumab in Acute Urticaria Irresponsive to Systemic Steroids: A Retrospective Analysis. [PDF]
Kang DH, Lew BL, Kwon SH.
europepmc +1 more source
Biologic Therapies and Biomarkers in Severe Childhood Asthma: A Systematic Review of Omalizumab and Mepolizumab. [PDF]
Gusmão ABF +7 more
europepmc +1 more source
Racial and socioeconomic disparities exist in pediatric food allergy patients pursuing omalizumab. [PDF]
Kichline T +4 more
europepmc +1 more source
Combination biologic therapy in bullous pemphigoid: two case reports and a focused review. [PDF]
Kyriakou A +9 more
europepmc +1 more source

